[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"enlarged-prostate-with-lower-urinary-tract-symptoms\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:enlarged-prostate-with-lower-urinary-tract-symptoms":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,45,70],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":30,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100643481","ejaculatory-sparing-holep-vs-standard-holep-100643481",false,"NCT07631286","Ejaculatory-Sparing HoLEP vs Standard HoLEP","Ejaculatory-sparing Holmium Laser Enucleation of the Prostate (HoLEP) vs Standard HoLEP: a Randomized Controlled Trial","Inclusion Criteria:\n\n\\- Patients who are sexually active with antegrade ejaculation who are undergoing HoLEP for the treatment of bothersome lower urinary tract symptoms.\n\nExclusion Criteria:\n\n* Patients with pre-existing retrograde ejaculation\n* Patients who are not sexually active\n* Patients with indwelling urinary catheter prior to surgery, neurological disease, or history of prior prostatic\u002Furethral surgery that may impact ejaculation\n* Patients who lack decisional capacity\n* Patients unable to read\u002Fspeak English",true,"MALE","18 Years","100 Years",{"count":21,"type":22},48,"ESTIMATED","INTERVENTIONAL",[25],"NA","The objective of this study is to compare a new surgical technique for HoLEP that will allow for sparing of ejaculation post-HoLEP.",[28,29],"Enlarged Prostate (BPH)","Enlarged Prostate With Lower Urinary Tract Symptoms",[31],"HoLEP","RECRUITING","2026-06-05",{"date":35,"type":36},"2026-06-09","ACTUAL",{"date":38,"type":22},"2026-06",{"date":40,"type":22},"2028-05",{"name":42,"class":43},"Northwestern University","OTHER",1,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":16,"sex":17,"minAge":52,"maxAge":53,"enrollmentInfo":54,"targetDuration":4,"studyType":23,"phases":56,"briefSummary":57,"conditions":58,"keywords":60,"overallStatus":62,"whyStopped":4,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":66,"completionDateStruct":67,"leadSponsor":69,"locationsCount":44},"100637217","emsella-for-reducing-tsui-after-holep-100637217","NCT07580404","Emsella for Reducing tSUI After HOLEP","The Utility of Emsella for Reducing Transient Stress Urinary Incontinence (tSUI) Following Holmium Laser Enucleation of the Prostate (HoLEP)","Inclusion Criteria:\n\n* Prostate sizing 80-150g\n* Ability to independently transfer and tolerate all 30min Emsella treatments (e.g. not wheelchair bound, no mobility issues)\n* Baseline M-ISI scores \\\u003C4\n* Same-day catheter removal and discharge\n* Able to read, understand, and complete surveys and questionnaires\n\nExclusion Criteria:\n\n* Catheter dependence\n* Previous BPH procedure\n* Previous pelvic surgeries\n* Pre-existing pelvic floor dysfunction\n* Neurogenic bladder\n* Overactive bladder - e.g. prescribed and taking any oxybutynin or mirabegron\n* Preoperative pad-use for incontinence","50 Years","80 Years",{"count":55,"type":22},30,[25],"This study aims to investigate the effectiveness of the Emsella chair treatments at different timepoints. Before and after the holmium laser enucleation of the prostate (HoLEP).",[59,29,28],"Benign Prostatic Hyperplasia",[31,61],"Emsella","NOT_YET_RECRUITING","2026-05-05",{"date":65,"type":36},"2026-05-12",{"date":38,"type":22},{"date":68,"type":22},"2028-06",{"name":42,"class":43},{"id":71,"slug":72,"hasResults":11,"nctId":73,"briefTitle":74,"officialTitle":75,"acronym":4,"eligibilityCriteria":76,"healthyVolunteers":11,"sex":17,"minAge":77,"maxAge":78,"enrollmentInfo":79,"targetDuration":4,"studyType":23,"phases":81,"briefSummary":83,"conditions":84,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":44},"100553824","phase-3-medications-for-lower-urinary-tract-symptoms-secondary-to-benign-prostatic-hyperplasia-100553824","NCT06491108","Medications for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia","Vardenafil Versus Tadalafil Versus Tamsulosin in Patients With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Prospective Randomized Study.","Inclusion Criteria:\n\n1. Sexually active patients .\n2. ModerateBPH related LUTS ( bengin prostatic hyperplasia related lower urinary tract symtoms ) i.e: (international prostatic symptom score 8 to 19 : the higher score is the worse symptoms ).\n3. Patients accepted medical treatment and completed 12 weeks on medical treatment and strict follow up .\n\nExclusion Criteria:\n\n1. Indication for combined therapy as prostate size over 40 gm .\n2. Gross hematuria.\n3. Refractory urine retention .\n4. Bilateral hydro-ureteronephrosis or renal insufficiency secondary to bengin prostatic hyperplasia.\n5. Bladder diverticula or calculi .\n6. History of bladder or prostate cancer.\n7. Unwilling patients to medical therapy.\n8. History of pelvic surgery or urethral stricture.","40 Years","70 Years",{"count":80,"type":22},150,[82],"PHASE3","The main objective of this prospective randomized controlled study is to compare safety and efficacy of Vardenafil versus Tadalafil versus Tamsulosin in terms of (voiding function, sexual function and quality of life) in the management of moderate BPH related LUTS.",[29],"2024-07-05",{"date":87,"type":36},"2024-07-08",{"date":89,"type":36},"2024-06-01",{"date":91,"type":22},"2025-07-01",{"name":93,"class":43},"Tanta University"]